WHO prequalifies diagnostic test to support safer administration of P. vivax malaria treatments
IVD
Medopharm’s chewable albendazole tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
- NT012 Albendazole Tablets, Chewable 400mg – Medopharm - INDIA
Active Pharmaceutical Ingredient (API) Prequalified
M
Dihydroartemisinin manufactured by Guilin Pharmaceutical Co., Ltd.
Mylan’s nirmatrelvir + ritonavir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
MSN Laboratories’ bedaquiline tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
TB395 Bedaquiline fumarate Tablet 100mg - MSN Lab - INDIA
Presentations 2024 Joint UNICEF-UNFPA-WHO Meeting available
ID
IVD
IS
M
V
VCP
The presentations of the 2024 Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers which took place from 2 to 6 December 2024 at UN City, Copenhagen, Denmark are now available at: